Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? - GLP-1 might play one too
- PMID: 32333969
- PMCID: PMC7175913
- DOI: 10.1016/j.diabres.2020.108160
Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? - GLP-1 might play one too
Conflict of interest statement
Declaration of Competing Interest I have no conflicts of interest to declare.
Comment on
-
COVID-19 and diabetes: Can DPP4 inhibition play a role?Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26. Diabetes Res Clin Pract. 2020. PMID: 32224164 Free PMC article. No abstract available.
References
-
- Labherz C., Kahles F., Piotrowski K., Vogeser M., Foldenauer A.C., Nassau K. Interleukin-6 predicts inflammation induced increase of Glucagon like peptide 1 in humans in response to cardiac surgery with association to parameters of glucose metabolism. Cardiovasc Diabetol. 2016;15(21):1–6. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
